Annual CFO
$374.94 M
+$180.50 M+92.83%
31 December 2023
Summary:
Bio-Rad Laboratories annual cash flow from operations is currently $374.94 million, with the most recent change of +$180.50 million (+92.83%) on 31 December 2023. During the last 3 years, it has fallen by -$210.03 million (-35.90%). BIO annual CFO is now -43.99% below its all-time high of $669.46 million, reached on 31 December 2021.BIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$163.61 M
+$65.96 M+67.55%
30 September 2024
Summary:
Bio-Rad Laboratories quarterly cash flow from operations is currently $163.61 million, with the most recent change of +$65.96 million (+67.55%) on 30 September 2024. Over the past year, it has increased by +$65.90 million (+67.44%). BIO quarterly CFO is now -44.42% below its all-time high of $294.38 million, reached on 31 December 2020.BIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$412.10 M
+$65.90 M+19.04%
30 September 2024
Summary:
Bio-Rad Laboratories TTM cash flow from operations is currently $412.10 million, with the most recent change of +$65.90 million (+19.04%) on 30 September 2024. Over the past year, it has increased by +$38.54 million (+10.32%). BIO TTM CFO is now -48.03% below its all-time high of $792.98 million, reached on 30 September 2021.BIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +92.8% | +67.4% | +10.3% |
| 3 y3 years | -35.9% | -29.0% | -48.0% |
| 5 y5 years | +31.3% | +64.0% | +2.2% |
BIO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -44.0% | +92.8% | -29.0% | +1383.7% | -48.0% | +111.9% |
| 5 y | 5 years | -44.0% | +92.8% | -44.4% | +1383.7% | -48.0% | +111.9% |
| alltime | all time | -44.0% | +9273.6% | -44.4% | +391.1% | -48.0% | +4782.9% |
Bio-Rad Laboratories Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $163.61 M(+67.6%) | $412.10 M(+19.0%) |
| June 2024 | - | $97.65 M(+39.9%) | $346.20 M(-0.1%) |
| Mar 2024 | - | $69.79 M(-13.9%) | $346.62 M(-7.6%) |
| Dec 2023 | $374.94 M(+92.8%) | $81.05 M(-17.1%) | $374.94 M(+0.4%) |
| Sept 2023 | - | $97.71 M(-0.4%) | $373.55 M(+30.2%) |
| June 2023 | - | $98.07 M(-0.1%) | $286.87 M(+18.5%) |
| Mar 2023 | - | $98.12 M(+23.2%) | $242.07 M(+24.5%) |
| Dec 2022 | $194.45 M(-71.0%) | $79.66 M(+622.4%) | $194.45 M(-31.9%) |
| Sept 2022 | - | $11.03 M(-79.3%) | $285.66 M(-43.4%) |
| June 2022 | - | $53.27 M(+5.5%) | $504.99 M(-16.7%) |
| Mar 2022 | - | $50.49 M(-70.4%) | $606.35 M(-9.4%) |
| Dec 2021 | $669.46 M(+14.4%) | $170.87 M(-25.8%) | $669.46 M(-15.6%) |
| Sept 2021 | - | $230.36 M(+49.0%) | $792.98 M(+13.6%) |
| June 2021 | - | $154.62 M(+36.1%) | $698.28 M(+9.8%) |
| Mar 2021 | - | $113.61 M(-61.4%) | $635.77 M(+8.7%) |
| Dec 2020 | $584.97 M(+27.8%) | $294.38 M(+117.0%) | $584.97 M(+29.9%) |
| Sept 2020 | - | $135.66 M(+47.3%) | $450.40 M(+8.7%) |
| June 2020 | - | $92.12 M(+46.7%) | $414.48 M(-13.2%) |
| Mar 2020 | - | $62.81 M(-60.7%) | $477.76 M(+4.3%) |
| Dec 2019 | $457.90 M(+60.4%) | $159.80 M(+60.2%) | $457.90 M(+13.6%) |
| Sept 2019 | - | $99.75 M(-35.8%) | $403.10 M(+10.2%) |
| June 2019 | - | $155.40 M(+261.9%) | $365.63 M(+26.9%) |
| Mar 2019 | - | $42.94 M(-59.1%) | $288.09 M(+0.9%) |
| Dec 2018 | $285.49 M(+174.2%) | $105.01 M(+68.6%) | $285.49 M(+14.3%) |
| Sept 2018 | - | $62.28 M(-20.0%) | $249.85 M(+15.6%) |
| June 2018 | - | $77.86 M(+93.0%) | $216.05 M(+7.7%) |
| Mar 2018 | - | $40.35 M(-41.8%) | $200.69 M(+92.7%) |
| Dec 2017 | $104.14 M(-51.8%) | $69.36 M(+143.6%) | $104.14 M(-19.6%) |
| Sept 2017 | - | $28.48 M(-54.4%) | $129.52 M(-15.2%) |
| June 2017 | - | $62.50 M(-211.2%) | $152.66 M(-8.8%) |
| Mar 2017 | - | -$56.20 M(-159.3%) | $167.31 M(-22.6%) |
| Dec 2016 | $216.07 M(+16.0%) | $94.75 M(+83.6%) | $216.07 M(+37.4%) |
| Sept 2016 | - | $51.61 M(-33.1%) | $157.27 M(-16.3%) |
| June 2016 | - | $77.16 M(-1135.9%) | $187.94 M(+25.9%) |
| Mar 2016 | - | -$7.45 M(-120.7%) | $149.32 M(-19.8%) |
| Dec 2015 | $186.21 M(-31.9%) | $35.95 M(-56.3%) | $186.21 M(-2.2%) |
| Sept 2015 | - | $82.28 M(+113.5%) | $190.47 M(-4.2%) |
| June 2015 | - | $38.53 M(+30.9%) | $198.85 M(-16.2%) |
| Mar 2015 | - | $29.45 M(-26.8%) | $237.19 M(-13.2%) |
| Dec 2014 | $273.31 M(+61.6%) | $40.22 M(-55.6%) | $273.31 M(-10.0%) |
| Sept 2014 | - | $90.65 M(+17.9%) | $303.65 M(+13.4%) |
| June 2014 | - | $76.87 M(+17.2%) | $267.82 M(+27.1%) |
| Mar 2014 | - | $65.57 M(-7.1%) | $210.69 M(+24.6%) |
| Dec 2013 | $169.14 M(-36.5%) | $70.55 M(+28.7%) | $169.14 M(-8.5%) |
| Sept 2013 | - | $54.83 M(+177.8%) | $184.82 M(-8.2%) |
| June 2013 | - | $19.74 M(-17.8%) | $201.33 M(-21.1%) |
| Mar 2013 | - | $24.02 M(-72.1%) | $255.24 M(-4.2%) |
| Dec 2012 | $266.48 M(+1.4%) | $86.24 M(+20.9%) | $266.48 M(+1.8%) |
| Sept 2012 | - | $71.34 M(-3.1%) | $261.74 M(+8.4%) |
| June 2012 | - | $73.64 M(+108.9%) | $241.56 M(-13.2%) |
| Mar 2012 | - | $35.26 M(-56.7%) | $278.21 M(+5.9%) |
| Dec 2011 | $262.74 M(+16.3%) | $81.50 M(+59.3%) | $262.74 M(-6.7%) |
| Sept 2011 | - | $51.16 M(-53.6%) | $281.63 M(-5.3%) |
| June 2011 | - | $110.30 M(+457.6%) | $297.33 M(+33.1%) |
| Mar 2011 | - | $19.78 M(-80.3%) | $223.42 M(-1.1%) |
| Dec 2010 | $225.91 M(-30.5%) | $100.39 M(+50.1%) | $225.91 M(-6.4%) |
| Sept 2010 | - | $66.87 M(+83.8%) | $241.24 M(-11.3%) |
| June 2010 | - | $36.39 M(+63.4%) | $271.87 M(-20.3%) |
| Mar 2010 | - | $22.27 M(-80.8%) | $340.97 M(+4.9%) |
| Dec 2009 | $325.07 M(+69.9%) | $115.72 M(+18.7%) | $325.07 M(+13.0%) |
| Sept 2009 | - | $97.49 M(-7.6%) | $287.69 M(+21.7%) |
| June 2009 | - | $105.49 M(+1555.8%) | $236.32 M(+18.2%) |
| Mar 2009 | - | $6.37 M(-91.9%) | $199.92 M(+4.5%) |
| Dec 2008 | $191.37 M(-0.1%) | $78.34 M(+69.9%) | $191.37 M(-11.5%) |
| Sept 2008 | - | $46.12 M(-33.2%) | $216.18 M(-3.9%) |
| June 2008 | - | $69.09 M(-3273.5%) | $225.06 M(+11.4%) |
| Mar 2008 | - | -$2.18 M(-102.1%) | $202.04 M(+5.5%) |
| Dec 2007 | $191.58 M | $103.15 M(+87.6%) | $191.58 M(+33.7%) |
| Sept 2007 | - | $55.00 M(+19.4%) | $143.29 M(+2.2%) |
| June 2007 | - | $46.07 M(-464.5%) | $140.17 M(-5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$12.64 M(-123.0%) | $147.66 M(+24.9%) |
| Dec 2006 | $118.23 M(+9.2%) | $54.86 M(+5.8%) | $118.23 M(+4.9%) |
| Sept 2006 | - | $51.87 M(-3.2%) | $112.76 M(+22.6%) |
| June 2006 | - | $53.56 M(-227.3%) | $91.96 M(+122.5%) |
| Mar 2006 | - | -$42.07 M(-185.2%) | $41.33 M(-61.8%) |
| Dec 2005 | $108.28 M(-12.0%) | $49.39 M(+59.0%) | $108.28 M(-1.5%) |
| Sept 2005 | - | $31.07 M(+958.7%) | $109.92 M(+6.3%) |
| June 2005 | - | $2.94 M(-88.2%) | $103.37 M(-14.3%) |
| Mar 2005 | - | $24.88 M(-51.2%) | $120.67 M(-2.0%) |
| Dec 2004 | $123.09 M(-3.6%) | $51.03 M(+108.1%) | $123.09 M(+11.8%) |
| Sept 2004 | - | $24.52 M(+21.2%) | $110.14 M(-14.4%) |
| June 2004 | - | $20.24 M(-25.9%) | $128.59 M(-3.5%) |
| Mar 2004 | - | $27.31 M(-28.3%) | $133.23 M(+4.4%) |
| Dec 2003 | $127.64 M(+20.7%) | $38.08 M(-11.4%) | $127.64 M(+2.0%) |
| Sept 2003 | - | $42.97 M(+72.8%) | $125.17 M(+9.4%) |
| June 2003 | - | $24.87 M(+14.5%) | $114.38 M(+4.6%) |
| Mar 2003 | - | $21.72 M(-39.0%) | $109.34 M(+3.4%) |
| Dec 2002 | $105.76 M(+6.3%) | $35.61 M(+10.7%) | $105.76 M(-4.3%) |
| Sept 2002 | - | $32.18 M(+62.2%) | $110.56 M(+10.0%) |
| June 2002 | - | $19.83 M(+9.4%) | $100.47 M(-13.0%) |
| Mar 2002 | - | $18.14 M(-55.1%) | $115.42 M(+16.0%) |
| Dec 2001 | $99.50 M(+310.3%) | $40.41 M(+83.0%) | $99.50 M(+53.2%) |
| Sept 2001 | - | $22.08 M(-36.5%) | $64.97 M(+31.8%) |
| June 2001 | - | $34.78 M(+1470.4%) | $49.28 M(+52.6%) |
| Mar 2001 | - | $2.21 M(-62.3%) | $32.28 M(+33.1%) |
| Dec 2000 | $24.25 M(-46.1%) | $5.88 M(-8.1%) | $24.25 M(-40.1%) |
| Sept 2000 | - | $6.40 M(-64.0%) | $40.47 M(-7.8%) |
| June 2000 | - | $17.79 M(-405.5%) | $43.87 M(+16.1%) |
| Mar 2000 | - | -$5.82 M(-126.3%) | $37.78 M(-16.0%) |
| Dec 1999 | $45.00 M(+64.8%) | $22.10 M(+125.5%) | $45.00 M(+31.2%) |
| Sept 1999 | - | $9.80 M(-16.2%) | $34.30 M(+3.9%) |
| June 1999 | - | $11.70 M(+735.7%) | $33.00 M(+14.6%) |
| Mar 1999 | - | $1.40 M(-87.7%) | $28.80 M(+5.5%) |
| Dec 1998 | $27.30 M(+29.4%) | $11.40 M(+34.1%) | $27.30 M(+33.2%) |
| Sept 1998 | - | $8.50 M(+13.3%) | $20.50 M(-6.4%) |
| June 1998 | - | $7.50 M(-7600.0%) | $21.90 M(+0.9%) |
| Mar 1998 | - | -$100.00 K(-102.2%) | $21.70 M(+2.8%) |
| Dec 1997 | $21.10 M(-36.4%) | $4.60 M(-53.5%) | $21.10 M(-15.6%) |
| Sept 1997 | - | $9.90 M(+35.6%) | $25.00 M(+51.5%) |
| June 1997 | - | $7.30 M(-1142.9%) | $16.50 M(-31.5%) |
| Mar 1997 | - | -$700.00 K(-108.2%) | $24.10 M(-27.4%) |
| Dec 1996 | $33.20 M(-13.1%) | $8.50 M(+507.1%) | $33.20 M(-16.2%) |
| Sept 1996 | - | $1.40 M(-90.6%) | $39.60 M(-8.8%) |
| June 1996 | - | $14.90 M(+77.4%) | $43.40 M(+13.9%) |
| Mar 1996 | - | $8.40 M(-43.6%) | $38.10 M(-0.3%) |
| Dec 1995 | $38.20 M(-20.9%) | $14.90 M(+186.5%) | $38.20 M(+9.8%) |
| Sept 1995 | - | $5.20 M(-45.8%) | $34.80 M(-6.2%) |
| June 1995 | - | $9.60 M(+12.9%) | $37.10 M(-11.2%) |
| Mar 1995 | - | $8.50 M(-26.1%) | $41.80 M(-13.5%) |
| Dec 1994 | $48.30 M(+114.7%) | $11.50 M(+53.3%) | $48.30 M(-15.9%) |
| Sept 1994 | - | $7.50 M(-47.6%) | $57.40 M(+5.1%) |
| June 1994 | - | $14.30 M(-4.7%) | $54.60 M(+37.9%) |
| Mar 1994 | - | $15.00 M(-27.2%) | $39.60 M(+76.0%) |
| Dec 1993 | $22.50 M(+462.5%) | $20.60 M(+338.3%) | $22.50 M(-355.7%) |
| Sept 1993 | - | $4.70 M(-771.4%) | -$8.80 M(-269.2%) |
| June 1993 | - | -$700.00 K(-66.7%) | $5.20 M(+23.8%) |
| Mar 1993 | - | -$2.10 M(-80.4%) | $4.20 M(+5.0%) |
| Dec 1992 | $4.00 M(-2.4%) | -$10.70 M(-157.2%) | $4.00 M(-81.6%) |
| Sept 1992 | - | $18.70 M(-1200.0%) | $21.70 M(+933.3%) |
| June 1992 | - | -$1.70 M(-26.1%) | $2.10 M(-63.2%) |
| Mar 1992 | - | -$2.30 M(-132.9%) | $5.70 M(+39.0%) |
| Dec 1991 | $4.10 M(-66.1%) | $7.00 M(-877.8%) | $4.10 M(-1466.7%) |
| Sept 1991 | - | -$900.00 K(-147.4%) | -$300.00 K(-105.9%) |
| June 1991 | - | $1.90 M(-148.7%) | $5.10 M(+34.2%) |
| Mar 1991 | - | -$3.90 M(-250.0%) | $3.80 M(-68.6%) |
| Dec 1990 | $12.10 M(+23.5%) | $2.60 M(-42.2%) | $12.10 M(+27.4%) |
| Sept 1990 | - | $4.50 M(+650.0%) | $9.50 M(+90.0%) |
| June 1990 | - | $600.00 K(-86.4%) | $5.00 M(+13.6%) |
| Mar 1990 | - | $4.40 M | $4.40 M |
| Dec 1989 | $9.80 M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from operations?
- What is the all time high annual CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFO year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFO year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from operations?
- What is the all time high TTM CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFO year-on-year change?
What is Bio-Rad Laboratories annual cash flow from operations?
The current annual CFO of BIO is $374.94 M
What is the all time high annual CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from operations is $669.46 M
What is Bio-Rad Laboratories annual CFO year-on-year change?
Over the past year, BIO annual cash flow from operations has changed by +$180.50 M (+92.83%)
What is Bio-Rad Laboratories quarterly cash flow from operations?
The current quarterly CFO of BIO is $163.61 M
What is the all time high quarterly CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from operations is $294.38 M
What is Bio-Rad Laboratories quarterly CFO year-on-year change?
Over the past year, BIO quarterly cash flow from operations has changed by +$65.90 M (+67.44%)
What is Bio-Rad Laboratories TTM cash flow from operations?
The current TTM CFO of BIO is $412.10 M
What is the all time high TTM CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from operations is $792.98 M
What is Bio-Rad Laboratories TTM CFO year-on-year change?
Over the past year, BIO TTM cash flow from operations has changed by +$38.54 M (+10.32%)